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Abstract
Background: Children suffering from rheumatic disease are faced with multidimensional challenges that affect their
quality of life and family dynamics. Symptom management and monitoring of the course of the disease over time
are important to minimize disability and pain. Poor disease control and anticipation of the need for treatment
changes may be prompted by specialist medical follow-up and regular nurse-led consultations with the patient and
families, in which information and support is provided. The purpose of this study was to evaluate the impact of a
nurse-led telephone intervention or Telenursing (TN) compared to standard care (SC) on satisfaction and health
outcomes of children with inflammatory rheumatic diseases and their parents.
Methods: A multicentered, randomized, longitudinal, crossover trial was conducted with pediatrics outpatients newly
diagnosed with inflammatory rheumatic diseases. Participants were randomly assigned to two groups TN and SC for
12 months and crossed-over for the following 12 months. TN consisted of providing individualized affective support,
health information and aid to decision making. Satisfaction (primary outcome) and health outcomes were assessed
with the Client Satisfaction Questionnaire-8 and the Juvenile Arthritis Multidimensional Assessment Report, respectively.
A mixed effect model, including a group x time interaction, was performed for each outcome.
Results: Satisfaction was significantly higher when receiving TN (OR = 7.7, 95% CI: 1.8–33.6). Morning stiffness
(OR = 3.2, 95% CI: 0.97–7.15) and pain (OR = 2.64, 95% CI: 0.97–7.15) were lower in the TN group. For both
outcomes a carry-over effect was observed with a higher impact of TN during the 12 first months of the
study. The other outcomes did not show any significant improvements between groups.
Conclusion: TN had a positive impact on satisfaction and on morning stiffness and pain of children with
inflammatory rheumatic diseases and their families. This highlights the importance of support by specialist nurses in
improving satisfaction and symptom management for children with inflammatory rheumatisms and their families.
Trial registration: ClinicalTrial.gov identifier: NCT01511341 (December 1st, 2012).
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Background
Pediatric rheumatic diseases comprise a large group of
inflammatory and non-inflammatory diseases of the
locomotion system and are considered as an important
pediatric chronic illness worldwide. In the US, 300′000
children are affected by rheumatic diseases; it is 100′00
more than those with juvenile diabetes [1]. In
Switzerland, the annual incidence rate was 40.6 new pa-
tients per 100,000 children, with 56.8/100,000 in the
Canton of Vaud (Western Switzerland); about two thirds
were diagnosed with an inflammatory disease [2].
Juvenile idiopathic arthritis (JIA) is the most common
form of rheumatic diseases [3]. Children and adolescents
with JIA commonly experience chronic pain, decreased
functional ability, impaired physical development, de-
creased overall well-being and quality of life, and emo-
tional, social, and school functioning when compared to
healthy individuals [4, 5]. Currently, there is no cure and
heavy treatments involving medication such as anti-
inflammatory drugs, corticosteroid injections, and TNF
alpha blockers; surgery and occupational therapy. Those
treatments are challenging for children and their fam-
ilies. Families have to learn how to adjust to their child’s
needs, and also how to mobilize their resources to main-
tain their own health and positive mental images, and
manage their uncertainty, anxiety, and distress [6, 7]. In
our centre, unpublished pilot data showed that families
of children with rheumatic disease were not entirely sat-
isfied (median score of 26.8 ± 3.4/32), especially due to
the lack of contacts with health professionals between
follow-up medical visits.
Caring for children with rheumatic chronic disease in-
volves a multidisciplinary approach. In addition to med-
ical care, nurses play a key role in supporting the
specialist team caring for these patients, recognizing
poor disease control and the need for changes in treat-
ment, providing information on treatment options and
how to access additional support. Nurses also ensure the
link between medical practitioner, other health pro-
viders, and family. These types of nursing care can be
provided via telephone, so called Telenursing (TN) [8].
Impact of TN has mostly been studied in adult pa-
tients with chronic disease and showed decreased
hospitalization rates, emergency department visits, ex-
acerbations, hospitalizations number, and mean duration
of bed days [9–13]. In the pediatric setting, the literature
review highlighted the paucity of studies demonstrating
strong evidence of the benefits of TN. In some studies in-
volving children with complex special healthcare needs,
TN interventions were more geared towards alleviating
physicians’ workload and compensating for subspecialist
shortage [14–16]. In studies targeting parents and children
directly, TN was done via a Helpline for parents of chil-
dren with congenital anomalies [17], or suffering from
gastroenteritis [18] or via Smartphone text for mothers
and children undergoing tonsillectomy [17–19]. To the
best of our knowledge, no studies testing the effect of TN
in pediatric ambulatory care for children with chronic dis-
ease have been published so far. This study aims to test
the impact of a nursing consultation via telephone on




A randomized crossover, experimental longitudinal design
was used in this study (see protocol published elsewhere)
[20]. This article presents the quantitative component of
this study.
Setting and participants
The setting was a tertiary referral pediatric rheumatology
outpatient clinic, serving all French-speaking cantons of
Switzerland. Every year, about 110 new patients are ad-
mitted to the clinic; about 50 of them have chronic in-
flammatory rheumatic diseases.
The study participants were the designated users of
the nursing telephone consultation, therefore included
parents of children ≤11 years or children from 12 years
of age. Children newly diagnosed (within 18 months
prior to the enrolment date) with an inflammatory
rheumatic disease, including JIA, connective tissue
disease, and vasculitis and under the age of 16 at enrol-
ment or their parents were eligible. Upon agreement to
study participation, informed consent and witten assent
were provided by parents and children (aged between 11
and 16), respectively. Potential participants that did not
understand and speak French and/or had no access to a
telephone were excluded.
Recruitment and randomization procedures
The study and its amendment were approved by the
Human Research Ethics Committee of the canton of
Vaud, Switzerland on January 17, 2011 and March 28,
2011, respectively. Parents and patients who attended
the pediatric rheumatology outpatient clinic between
January 2010 and August 2012 and consented were en-
rolled in the study for a total of 24 months. Briefly, this
study was a randomized, crossover trial, in which pa-
tients were their own control [21]. The intervention
(TN) was evaluated against standard care (SC) with the
same subjects. It is worth noting that TN was provided
in addition to SC, thus all participants received SC for
the whole duration of this study. Participants were
randomized and allocated to group 1 or group 2 using
a computer-generated simple block randomization to
account for different level of severity of illness. Treat-
ment allocation was in sealed numbered envelopes.
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Both groups received 12 months of TN and 12 months
of SC, only the attribution order varied; (group 1 re-
ceived TN first and then SC and group 2 received SC
first and then TN).
Theoretical framework and delivery of the intervention
The Cox’s Interaction Model of Client Health Behavior
(IMCHB), which was developed to direct and document
nursing evaluation and care and reach positive nursing
intervention effects on health outcome, was used to
guide this study [22]. The main objective of this nurse-
led intervention was to ensure continuity of care for
children and their families. TN provided by specialized
nurses via telephone included provision of individualized
health information, affective support and help in deci-
sion making. Two qualified specialist nurses with over
five years of experience in adult and pediatric rheuma-
tology were specifically trained (3 day course) in TN oral
communication, strategies for questioning parents and
adolescents, assessing the quality of interactions and aid-
ing decision making for the TN. A two-part standardized
form of telephone interviewing was developed for each
TN consultation. The first part included description of
the call, such as time, initiator and nature of the call,
action/decision taken, and a brief summary of the
conversation and planned action. The second part re-
lated to the intervention itself and included eight
questions on: 1) everyday life, school and social, 2) treat-
ment, 3) physiotherapy, 4) occupational therapy, 5) pain,
6) schedule, 7) administrative issues, 8) any additional
topic that the respondent would like to discuss.
Experimental group
As per cross-over design, all participants received the
intervention (TN), either during the first 12 months or
the last 12 months of the study. When in the TN group,
participants attended a first face-to-face medical and
nursing consultation at the start of TN (T0 for group 1;
T12 for group 2). This visit allowed the TN nurse to
introduce herself, explain how the telephone consult-
ation would be carried out and get to know the child’s
clinical, social and family situation. For the following
12 months, the participants received a monthly tele-
phone call. In addition, the participating parent or child
was given a telephone number to contact, when needed,
the TN nurse on duty during normal office hours on
week days.
Control group
As per cross-over design, all participants included were
part of the control group, either during the first
12 months or the last 12 months of the study. Partici-
pants in the control group received SC, in which
medical management was provided by a pediatric
rheumatologist mainly, but also by other specialists
(occupational therapists) as determined by patients’
needs. When in the SC group, participants attended a
face-to-face medical consultation only, at the start of SC
(T12 for group 1, T0 for group 2). The medical consult-
ation was repeated every three months and participants
were followed and treated as per standard practice. Par-
ents were also informed that they could call the out-
patient clinic.
Measures
The choice of data collection points and the study time
span was based on theoretical and practical consider-
ations [23]. Face-to-face consultation baseline data
(demographics, health status, and satisfaction) were col-
lected at T0. Demographic data about participants in-
cluded age, gender, cultural background, marital status,
occupation, education, language spoken at home, and
types of treatment. Collection points occurred every
three months for disease activity and health status assess-
ment (T3, T6, T9, T12, T15, T18, T21 and T24) and every
six months for satisfaction (T6, T12, T18 and T24).
Outcomes
The study’s primary outcome was participants’ satisfac-
tion (child/parent). Satisfaction was assessed using the
Client Satisfaction Questionnaire-8 (CSQ-8), an 8-item
version of the 18-item CSQ [24]. It is brief to administer,
has good psychometric properties, and has been trans-
lated and validated in French. Each item of the CSQ-8
items is rated on a 4-point Likert-type scale giving a
total score ranging between 8 (no satisfaction) and 32
(total satisfaction), a score ≥ 30 indicates satisfactory rat-
ing of satisfaction and a score < 30 a lack of satisfaction.
Test comparison was the proportion of subjects who
were satisfied in each group as well as changes in satis-
faction scores within groups (between T0 and T12).
Secondary outcomes were clinical health status mea-
surements performed every three months as per standard
practice, using the Juvenile Arthritis Multidimensional
Assessment Report (JAMAR) French version, of which
original version was translated and validated [25–27]. The
JAMAR includes 15 self-reported measures that assess
well-being, pain, functional status, health-related quality
of life, morning stiffness, disease activity, disease status
and course, joint disease, extraarticular symptoms, side ef-
fects of medications, therapeutic compliance, and satisfac-
tion with illness outcome. For children too young to self-
report, the parent version of the JAMAR was used. In this
study, the items of interest were: (1) Assessment of func-
tional ability through a 15-item questionnaire, in which
the ability of the child to carry out daily living activities is
scored: 0 = without difficulty, 1 = with difficulty, 2 = unable
to do. A total score of 0 was considered as no difficulty in
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functional ability and a total score of ≥1 was considered as
having some difficulty; (2) Rating of the intensity of child’s
pain on a 21-point visual analogue scale (VAS) (0 = no
pain; 10 = extreme pain). A total score of ≤3 was consid-
ered as no pain and a total of 3 was considered as hav-
ing pain; (4) Assessment of morning stiffness was a “yes-
no” item; (5) Assessment of extraarticular symptoms was
two “yes- no” questions assessing fever and rash; (7) Rat-
ing of disease status at the time of the visit as remission,
continued activity, or relapse; (8) Rating of disease course
from previous visit as much improved, slightly improved,
stable/unchanged, slightly worsened or much worsened
(improvement of disease status was assessed when partici-
pants answered “remission” at item 7 and “much im-
proved” or “slightly improved” at item 8); (14) Assessment
of health-related quality of life was performed through a
10-item questionnaire having two dimensions, physical
health and psychosocial health, composed of 5 items each.
The responses were “never” (score = 0), “sometimes”
(score = 1), “most of the time” (score = 2), and “all the
time” (score = 3). Separate scores for the physical and psy-
chosocial subscales can also be calculated. A total score of
0 was considered as no difficulty in quality of life and a
total of ≥1 was considered as having difficulty in quality of
life. Same quotation was applied to the subscales.
The study’s secondary comparisons were the propor-
tion of subjects that had: i) no morning stiffness; ii) no
pain; iii) no difficulty in functional capacity; iv) in remis-
sion; v) no difficulty in physical quality of life and vi) no
difficulty in psychosocial quality of life in both groups.
Statistical analysis
Sample size and power were predicted based on the
number of newly diagnosed children with inflammatory
rheumatic diseases admitted to the study hospital’s
paediatric rheumatology outpatients 2008 (N = 48). We
anticipated that around 70 children would be admitted
to the clinic in the 18-month screening period prior to
enrolment into the study and considered that 80% of pa-
tients/parents would give consent to their participation
(N = 56).
A power analysis was calculated based on the number
of participants expected to complete the study, not the
number recruited initially. For 50% difference in the pro-
portion of subjects with a satisfaction score ≥ 30 (cut-off
score) between the two groups, 23 subjects per group
was required to reach a power level of .90 for an alpha
level of .05 (two-sided test). To compensate for an ex-
pected attrition rate of 20%, we aimed to recruit 28 sub-
jects in each group (total of 56 subjects).
An intention to treat analysis was performed. Random
intercept mixed effect linear models were used for con-
tinuous outcomes and random intercept logistic mixed
models for binary outcomes. The models tested the
effect of treatment (TN or SC), period (year) and the
interaction between treatment and period. Prior to data
analyses, data were screened for data file’s accuracy,
missing data, outliers, and distribution [28]. Data ana-
lyses were performed using Stata version 13 software
(StataCorp LP, College Station, TX, USA).
Results
Participant flow
Figure 1 summarizes the recruitment and group’s al-
location. Of 711 children initially screened, 120 were
eligible and 55 (46%) consented to participate and
were included. Participants were randomized and allo-
cated to group 1 that received TN the first 12 months
and then SC (n = 30) or group 2 that received SC
first and then TN (n = 25). After 12 months, one
participant of group 2 withdrew from the study. After
24 months two additional participants withdrew from
group 1.
Baseline data
Table 1 shows demographics of respondents at baseline.
Responding children (n = 24, females 58.3%) had a mean
age of 13.1 years, most of them were born in Switzerland
and were still in school (87.5%). Responding parents
(n = 31, 96.8% females) were mostly Swiss (71%), work-
ing (90.4%) and married (74.2%). Table 2 shows children
clinical characteristics with the majority of them diag-
nosed with some form of JIA (70.5%), predominantly
with juvenile enthesitis-related arthritis (ERA) (29%) or
with oligoarticular JIA (27%). Other diagnosis included;
uveitis (5.4%), chronic osteomyelitis (3.6%), chronic in-
fantile neurological cutaneous articular (CINCA) syn-
drome (1.8%), lupus (1.8%), Crohn’s disease (1.8%),
Behçet syndrome (1.8%), auto-inflammatory disease
(1.8%) and juvenile dermatomyositis (JDM) (1.8%), with
a few undetermined conditions (7.3%). Disease severity
was assessed, by the treating physician using the Juvenile
Arthritis Disease Activity Score (JADAS) as per standard
practice and showed that most children had mild to
moderate condition (90%) versus severe (10%).
Satisfaction
Proportions of participant who were satisfied (CSQ-8
score ≥ 30) are reported in Table 3. At T12 and T24, the
interaction between the treatment and the year was not
significant. A model without this interaction compared
the TN and SC impact on satisfaction independently of
the year it was received and showed that probability of
being satisfied (satisfaction scores ≥30) was 8 times
higher at the End of the TN period when compared to
SC (OR = 7.7, 95% CI: 1.8–33.6). Satisfaction scores pro-
gressively increased by 20% from T0 to T12 in the TN
group. An opposite negative trend was observed in the
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SC group, where satisfaction progressively decreased by
60% between T0 and T12.
Secondary outcomes
Morning stiffness
Participant’s proportions of having no morning stiff-
ness, (item 4 of JAMAR), are reported in Table 3. At
T12 and T24, there was a significant interaction be-
tween the treatment (TN or SC) and the year
(p < 0.001) indicating a treatment carry-over from the
first to the second year. Participants in group 1, who
received the TN during the first year (80% without
stiffness), maintained better results throughout their
second year when they reversed to SC (97% with no
stiffness). In contrast, participants in group 2, who
started with SC (60% with no stiffness) and benefitted
from the TN during their second year, maintained
lower results (78% with no stiffness).
Due to this carry over treatment effect, the logistic re-
gression analysis included the first year results only. Re-
sults indicated that the probability of having no morning
stiffness would be 3 times greater after TN than after SC
(OR = 3.2, 95% CI: 0.97–7.15).
Pain
Participant’s proportions with no pain, which rated ≤3
on the 21-point VAS (item 2 of JAMAR) are reported in
Table 3.
At T12 and T24 there was a significant interaction be-
tween the treatment and the year (p < 0.001) indicating
a treatment carry-over effect from the first to the second
year. Participants in group 1, who received the TN dur-
ing the first year (91% with no pain), maintained better
results throughout the second year with SC (88% with-
out pain). In contrast, participants in group 2, who
started with SC (59% with no pain) and benefitted from
Fig. 1 Study enrollment and flow
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the TN during their second year maintained lower re-
sults (67% with no pain).
Due to this carry over effect, the logistic regression
analysis included the first year results only. Results
pointed to an upward trend, suggesting that the prob-
ability of having no pain would be greater after TN than
after SC, but this difference was not statistically signifi-
cant (OR = 2.64, 95% CI: 0.97–7.15).
Extraarticular symptoms
Participant’s proportions with extraarticular symptoms,
fever and rash, were not analysed because no more than
two patients had these symptoms at any time.
Functional capacity
Participant’s proportions with no difficulty in their func-
tional capacity, with a total score of 0 (item 1 of
JAMAR) are reported in Table 3.
At T12 and T24, the interaction between the treat-
ment and the year was not significant. A model without
this interaction compared the impact of TN and SC on
functional capacity independently of the year it was re-
ceived and showed no significant differences.
Disease status
Participant’s proportions of improvement in disease sta-
tus, who were in “remission” (item 7 of JAMAR) and for
whose disease course was either “much improved” or
“slightly improved” (item 8 of JAMAR) are reported in
Table 3.
Table 1 Baseline demographics of the study sample
Children Parents
Group 1 Group 2 Group 1 Group 2
TN→ SC a SC→ TN a TN→ SC a SC→ TN a
(n = 14) (n = 10) (n = 16) (n = 15)
Sex, female 8 (57%) 6 (60%) Sex, female 15 (94%) 15 (100%)
Country of birth Nationality
Switzerland 12 (86%) 8 (80%) Swiss 10 (63%) 12 (80%)
Europe 1 (7%) 2 (20%) European 6 (37%) 2 (13%)
United States 1 (7%) 0 African 0 1 (7%)
Education Professional activity
Primary School b 4 (29%) 6 (60%) Commercial 4 (25%) 5 (33%)
Secondary School b 8 (57%) 3 (30%) Catering 2 (13%) 1 (7%)
Post-education 2 (14%) 1 (10%) Management 1 (6%) 1 (7%)
Health 5 (31%) 4 (27%)
Non indicated 1 (6%) 1 (7%)
Respondents were either children or their parents. Results are expressed in total number and percentage
aAllocation order of TN = Telenursing; SC = standard care, for 12 months each
bBased on the harmonization of compulsory education (HarmoS) Swiss system
Table 2 Clinical characteristics of the study sample (children)
Group1 Group2
TN→ SC* SC→ TN*
(n = 30) (n = 25)
Diagnosis
Behçet syndrom 0 1 (4%)
JIA (enthesitis-related) 9 (30%) 7 (26%)
JIA (undifferenciated) 1 (3%) 2 (8%)
JIA (oligoarticular) 5 (17%) 10 (37%)
JIA (polyarticular) 0 4 (15%)
JIA (systemic) 1 (3%) 0
Chronic osteomyelitis 1 (3%) 1 (4%)
Auto-inflammatory disease 0 (0%) 1 (4%)
Juvenile dermatomyositis (JDM) 1 (3%) 0 (0%)
Uveitis 2 (7%) 1 (4%)
Chronic infantile neurological cutaneous
articular (CINCA) syndrom
1 (3%) 0
Lupus 1 (3%) 0
Crohn’s disease 1 (3%) 0
Undetermined 4 (13%) 0
Severity a
Mild/moderate 27 (90%) 23 (92%)
Severe 3 (10%) 2 (8%)
Allocation order of TN telenursing; SC standard care, for 12 months each. JIA
juvenile idiopathic arthritis
aSeverity of the disease was assessed prior randomization, by the treating
physician using the
JADAS
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At T12 and T24, the interaction between the treat-
ment and the year showed that this interaction was not
significant. A model without this interaction compared
the impact of TN and SC on disease status independ-
ently of the year it was received and showed no signifi-
cant differences.
Quality of life
Participant’s proportions with no difficulty in health-
related quality of life, with a total score of 0 (item 14 of
JAMAR), were analyzed globally and also specifically by
analyzing separately the scores of physical and psycho-
social health, and are reported in Table 3.
At T12 and T24, the interaction between the treat-
ment and the year was not significant for both physical
and psychosocial quality of life. A model without this
interaction compared the impact of TN and SC on
physical/ psychosocial quality of life independently of
the year it was received and showed no significant
differences.
Discussion
This multi-site randomized crossover study is, to the best
of our knowledge, the first study demonstrating the effect
of a TN intervention to support children/adolescent with
inflammatory rheumatic disease and their parents. Dur-
ing the course of their disease, participants in the inter-
vention group received tailored individualized affective
support, health information and assistance in decision
making that improved their satisfaction and impacted
positively on symptoms, such as morning stiffness and
pain. The intervention resulted in improvement of satis-
faction, with the probability of being satisfied 8 times
higher when compared to SC. Additionally, we observed
that satisfaction increased by 20% at the End of the full
period of the TN, whereas satisfaction decreased of 60%
throughout receiving SC. This shows that as time went
by, the interaction between the participant and the TN
nurse increased in quality with better tailored response
to individual needs and resulting in higher satisfaction
with care. These results also indicate that the Cox model
used in this study to conceptualize the intervention was
adequate. It also highlights the importance for this type
of intervention to be provided over a long period of time
and regularly for the interaction to take place. Initially,
this study was designed to respond to a need to fill in the
gaps of a lack of follow-up between medical consulta-
tions, where parents felt they had difficulties to reach out
to the appropriate person to find answers to day to day
problems related to their child’s conditions. Although it
concerns only a small proportion of all children attending
the clinic, the intervention in this study seems to have
appropriately responded to this need.
Supporting our results, satisfaction has been correlated
with telehealth interventions in other studies [29–33].
Improved satisfaction is a good indicator of high-quality
nursing care; a major determinant being that nurses
recognize participants’ concerns and adapt their care to
participants’ specific needs [34, 35]. In this study, satis-
faction was the most positively impacted outcome
Table 3 Observed proportions (%) of participants at T0, T6, T12, T18 and T24 for primary and secondary outcomes
Intervention allocation Proportions (%)
Outcomes T0 - T12 T12 -T24 T0 T6 T12 T18 T24
Satisfaction; CSQ-8 scores ≥30 TN SC 62 60 70 58 42
SC TN 44 38 29 54 54
No difficulty in functional capacity a TN SC 38 66 69 58 71
SC TN 42 52 54 63 64
No pain TN SC 70 73 85 78 82
SC TN 64 67 54 67 64
No morning stiffness TN SC 67 80 78 70 93
SC TN 80 71 58 79 77
Improvement of disease status b TN SC 25 38 36 27 33
SC TN 23 42 18 17 9
No difficulty in physical quality of life TN SC 37 48 52 40 64
SC TN 20 46 25 46 50
No difficulty in psychosocial quality of life TN SC 50 59 67 60 68
SC TN 46 50 58 58 59
aFunctional capacity defined as the ability to perform activities of daily living and other independent living skills
bDisease status is defined here by the occurrence of symptoms (absence, presence or recurrence) and course of disease from previous visit (improvement, stable
or worse)
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showing that children with inflammatory rheumatic dis-
eases and their family were appreciative of the support
and information provided by the Telenursing nurse.
These results are consistent with other studies per-
formed mainly in the adult population suffering from
chronic conditions such as diabetes, cancer, chronic pul-
monary disease, heart failure, complex endocrinology pa-
tients or Parkinson’s disease, where Telenursing had a
positive impact on several outcomes, including satisfac-
tion [13, 29–33, 36–39]. Telehealth in the pediatric
population has been less studied so far, but satisfaction
and patient’s perception have been investigated. Im-
proved communication and symptom management was
demonstrated in studies with an advanced symptom
management system (ASyMS©) for cancer patients
[40–44], and value of convenience, confirmation, sup-
port and guidance brought by TN was showed for
parents of children with gastroenteritis [18].
To a lesser extent, positive impacts on health out-
comes have also been correlated with telehealth inter-
ventions [29, 30, 32, 34, 45–47]. In our study we
demonstrated a positive impact of TN on morning stiff-
ness and pain, indicating that the intervention improved
symptom management. This result is in line with results
obtained in other studies where health outcomes, such
as metabolic control variable or symptom severity and
distress have been improved notably for patients suffer-
ing from chronic conditions, such as diabetes and
asthma [48, 49].
Our study had two limitations inherent to the choice
of crossover design: a carryover effect of the intervention
and a difference on intervention’s impact due to the
sequential and temporal allocation nature of the
intervention.
The carryover effect of the intervention and time im-
pacted pain and morning stiffness outcomes. It could
partly be explained by the lack of a wash-out period in
our study design. However, because we had 6 months
between the End of the intervention and the first meas-
ure in the SC group, providing theoretically enough time
for no carry-over effect of the intervention, we con-
cluded that a wash-out period was not necessary. Time
effect of the natural course of the disease may have in-
troduced some bias, as all participants received appro-
priate medical treatment that one can assume improved
outcomes with time. When there was a carry-over effect,
analyses were only performed in half of the data col-
lected during the first 12 months. It must be emphasized
that this type of analysis generates a decreased power in
the test due to the smaller size of the sample (n = 24
and n = 28).
Another feature of the design is that all participants
receive both TN and SC, and this could also explain a
diluted effect of the intervention. In fact, most studies
with a TN have different intervention allocation. In some
studied population was divided in two and one half was
only receiving TN and the other only receiving routine
care [9, 10]. In another study, all patients were receiving
the TN right away, and they were they own control for
evaluation of outcomes, before and after intervention
[37]. The aforementioned studies have shown a more
significant impact in the studied outcomes most prob-
ably because they compared the full force of the inter-
vention against no intervention or against baseline. In
our study, the cross-over design was chosen because it
allows for smaller sample size in a population, where the
incidence of the disease is relatively small, yet its impact
is significant when inappropriately managed.
The sequential allocation of the intervention impacted
all outcomes. Better impact on the outcomes in the
group TN receiving first as opposed to the one receiving
SC first was observed. This effect has probably been ex-
acerbated by the participant inclusion criterion of newly
diagnosed patients only. It is known that newly-
diagnosed patients with complex healthcare needs re-
quire close monitoring and time to adjust to the diagno-
sis, constraints of the treatment, and to cope with
doubts and uncertainty for the future [33]. Participants
receiving the TN first were likely to require more sup-
port and help than those who received the intervention
minimum one year after diagnosis. This could explain
better results in group 1. However, the positive impact
in group 2 should not be overlooked; albeit diminished,
it was still indicating usefulness of Telenursing in the
long term.
Finally, because blinding of participants was not pos-
sible in this study, it introduced potential biais in partici-
pants’ self-reported outcomes. Power calculation was
performed on the primary outcome only, therefore re-
sults related to secondary outcomes should be inter-
preted with caution. Further testing and economic
evaluation are warranted prior to implementation into
practice.
Conclusions
In summary, our Telenursing intervention combined
affective support, health information and assistance in de-
cision making in a new and effective approach. Patient
with inflammatory rheumatic diseases and family were
satisfied, and children tended to have less morning stiff-
ness and pain. This nurse-led telephone intervention has
the potential to reduce health problems, whilst increasing
patients’ and family’s satisfaction during the management
of chronic, debilitating pediatrics rheumatic disease, espe-
cially when administered in the newly-diagnosis period.
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